After years in drug development limbo, a compound that interrupts cell division has revitalized a troubled area of cancer research.
No takes yet. Share an insight, caveat, or question.
Ken Garber (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: